EULAV ASSET MANAGEMENT Intercept Pharmaceuticals, Inc. Transaction History

EULAV ASSET MANAGEMENT portfolio value:

$5.51M
portfolio value

EULAV ASSET MANAGEMENT quarter portfolio value change:

+1.01%
quarter

Intercept Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 55K $13.95 395K
Q2 2022 share Decrease -12.22% -55K shares -1.86M $13.81 395K
Q1 2022 share 0.00% 0 shares -9K $16.27 450K
Q4 2021 share Decrease -31.82% -210K shares -2.47M $16.31 450K
Q3 2021 share Increase +97.01% 325K shares 3.11M $14.85 660K
Q2 2021 share 0.00% 0 shares -1.04M $19.97 335K
Q1 2021 share 0.00% 0 shares -543K $23.08 335K
Q4 2020 share Increase +121.85% 184K shares 2.01M $24.7 335K
Q3 2020 share 0.00% 0 shares -974K $41.46 151K
Q2 2020 share 0.00% 0 shares -2.27M $47.91 151K
Q1 2020 share Decrease -9.58% -16K shares -11.18M $62.96 151K
Q4 2019 share Decrease -15.23% -30K shares 7.62M $123.92 167K
Q3 2019 share 0.00% 0 shares -2.60M $66.36 197K
Q2 2019 share Increase +9.44% 17K shares -4.39M $79.57 197K
Q1 2019 share Increase +146.58% 107K shares 12.71M $111.86 180K
Q4 2018 share Decrease -2.67% -2K shares -2.11M $100.79 73K
Q3 2018 share Decrease -6.25% -5K shares 2.76M $126.36 75K
Q2 2018 share 0.00% 0 shares 1.79M $83.91 80K
Q1 2018 share Increase +21.21% 14K shares 1.06M $61.52 80K
Q4 2017 share 0.00% 0 shares 25K $58.42 66K
Q3 2017 share Increase +26.92% 14K shares -2.46M $58.04 66K
Q2 2017 share 0.00% 0 shares 415K $121.07 52K
Q1 2017 share Increase +13.04% 6K shares 883K $113.1 52K
Q4 2016 share 0.00% 0 shares -2.57M $108.65 46K
Q3 2016 share Increase +17.95% 7K shares 2.00M $164.59 46K
Q2 2016 share Increase +25.81% 8K shares 1.58M $142.68 39K
Q1 2016 share Increase +6.90% 2K shares -348K $128.47 31K